Key facts
- It has raised $100K; the latest was Early Stage VC in Dec 2025.
- Notable investors include Capital Factory, Capita3.
- Status: Privately Held (backing).
Investors
2- ·The complete investor list — 2 names
- ·Watchlist + deal alerts for UViiVE
- ·The full record, as it builds
Funding rounds
No funding rounds for UViiVE are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About UViiVE
Developer of dermalogiic molecules designed to treat and prevent chronic and acute conditions of the skin, the human body's largest organ. The company is currently operating in Stealth Mode.
- Sector
- Healthcare
- HQ
- Shoreview, MN, United States
- Founded
- 2025
- Employees
- 3
- Website
- uviive.com/
- Ownership
- Privately Held (backing)
UViiVE doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in UViiVE shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on UViiVE in its N-PORT filings yet. We sweep new filings monthly.